Why Sleep Is Important With Diabetes

Why Sleep Is Important With Diabetes

Why Sleep Is Important With Diabetes

People with diabetes hear constantly to exercise, eat right, and check blood sugars. Doctors rarely mention the importance of sleep, but good sleep is among the best diabetes medicines.
A paper from Penn State University found that the risk of death from stroke and heart disease was significantly higher in people who get less than six hours of sleep a night. Researcher Julio Fernandez-Mendoza, PhD, said, short sleep “multiplies the risk of poor outcomes in people with CVD [cardiovascular disease] or stroke.” Heart disease and stroke are the leading causes of diabetes-related deaths.
“We have to look beyond sleep apnea,” said Dr. Fernandez-Mendoza. “Most of these patients without sleep apnea but with coronary vascular disease or stroke complain of poor sleep or chronic insomnia. We know now that when such objective short sleep is present their long-term prognosis is much worse.”
Obstructive sleep apnea (OSA) has been known for years to increase risk of Type 2 diabetes, heart disease, and early death. In sleep apnea, people stop breathing repeatedly while asleep, because their airways are blocked by relaxing throat muscles. They wake up to clear their throat so they can breathe and then fall back asleep, over and over, usually without being aware of it. Penn State researchers found that people with OSA had three times the risk of Type 2 diabetes and four times the risk of high blood pressure (hypertension.)
According to the American Sleep Association, “animal studies show that sleep is necessary for survival.” The immune system, our bodies’ repair system, is Continue reading

Rate this article
Total 1 ratings
Type 1 diabetes cured in mice using gene therapy

Type 1 diabetes cured in mice using gene therapy

Researchers from the University of Texas Health Science Center in San Antonio have found a way to cure type 1 diabetes in mice. It is hoped that the novel technique - which boosts insulin secretion in the pancreas - will reach human clinical trials in the next 3 years.
Study co-author Dr. Bruno Doiron, Ph.D., of the Division of Diabetes, and colleagues recently reported their findings in the journal Current Pharmaceutical Biotechnology.
Type 1 diabetes is estimated to affect around 1.25 million children and adults in the United States. Onset of the condition is most common in childhood, but it can arise at any age.
In type 1 diabetes, the immune system destroys the insulin-producing beta cells of the pancreas. Insulin is the hormone that regulates blood glucose levels. As a result, blood glucose levels become too high.
There is currently no cure for type 1 diabetes; the condition is managed through diet and insulin therapy. However, in recent years, researchers have investigated replacing beta cells as a means of eradicating type 1 diabetes once and for all.
Dr. Doiron and colleagues have taken a different approach with their new study. The team reveals how they used a method called gene transfer to coax other pancreatic cells into producing insulin.
Using this technique, the researchers have managed to cure type 1 diabetes in mice, bringing us one step closer to curing the condition in humans.
Gene transfer method led to long-term insulin secretion in mice
The gene transfer technique - called Cellular Networking, Integration and Processing - involves introducing specific g Continue reading

Invokana: Diabetes Drug Gets Black Box Warning for Amputation Risks

Invokana: Diabetes Drug Gets Black Box Warning for Amputation Risks

Invokana (canagliflozin), an SGLT-2 drug for use in type 2 diabetes and off-label in those with type 1 diabetes has been required by the FDA to carry the prominent boxed warning due to a higher risk for leg and foot amputations.
This new requirement is a result of two clinical trials whose data revealed these elevated risks. Canagliflozin is the drug present in the marketed products: Invokana, Invokamet, and Invokamet XR.
The clinical trials called CANVAS (Canagliflozin Cardiovascular Assessment Study) and CANVAS-R (A Study of the Effects of Canagliflozin on Renal Endpoints in Adult Participants With Type 2 Diabetes Mellitus) revealed that leg and foot amputations happened about twice as often in those taking canagliflozin compared to those taking a placebo.
Over the span of a year the amputation risk for CANVAS trial patients was equal to 5.9 out of every 1,000 patients taking canagliflozin and 2.8 out of every 1,000 patients taking a placebo.
Over the span of a year the amputation risk for CANVAS-R trial patients was equal to 7.5 out of every 1,000 patients taking canagliflozin and 4.2 out of every 1,000 patients taking a placebo.
Most common was toe and middle the foot amputations but below and above the knee leg amputations were also observed. Some patients needed multiple amputations, “some involving both limbs.”
This warning is in addition to last year’s FDA strengthened warning to users of canagliflozin for an increased risk of acute kidney injury and in 2015 the strengthened “warning for canagliflozin related to the increased risk of bone fractures,”
Sympt Continue reading

Studies Show Diabetes Drug Invokana Increases Amputation Risk

Studies Show Diabetes Drug Invokana Increases Amputation Risk

People with diabetes who take a class of drugs known as sodium–glucose cotransporter 2 (SGLT2) inhibitors will now need to weigh benefits against risks after studies showed the medications significantly reduce heart problems in subjects, but, surprisingly, also increase the risk of amputation.
The results of the studies on the Johnson & Johnson drug canagliflozin, marketed under the name Invokana, confirm cardiovascular benefits not only for that particular medication, but also for others in its class. Those same results, however, call into question whether other drugs in the class also contribute to increased amputation.
“Drugs to treat diabetes have been undergoing a positive transformation in the last three or four years,” says Dr. Bruce Neal, lead investigator in the study and professor of medicine for University of New South Wales Sydney, and senior director, the George Institute for Global Health in Sydney, Australia. “It used to be we would test diabetes drugs to see if they lowered glucose levels and did not cause heart problems. Now, we test drugs and expect to see them not only lower glucose but improve cardiovascular health. It’s been extraordinary. But, now we might be finding out that there are glitches along the way.”
Neal led a team of six other academic researchers combining data from two studies, the first a clinical trial before the drug was approved by the Food and Drug Administration in 2013 and the second a post-marketing study designed to detect any cardiovascular risks from the drug. Such studies are a recent requirement of the FDA to ensu Continue reading

Type 1 Diabetes Originates in the Gut But Probiotics Could Offer Cure

Type 1 Diabetes Originates in the Gut But Probiotics Could Offer Cure

Two separat
e pieces of research have found that the development of type 1 diabetes is likely caused by the gut, and therefore, a type of probiotic could be the cure.
Scientists from several European and US institutions studied 33 Finnish infants over three years from birth who were genetically predisposed to type 1 diabetes.
Their study, entitled “The Dynamics of the Human Infant Gut Microbiome in Development and in Progression toward Type 1 Diabetes” is published in the journal Cell Host & Microbe.
They discovered that four children in the group that developed type 1 diabetes had 25% less types of bacteria in their guts than other children.
The same four infants were also found to have more amounts of a specific bacteria that is known to trigger gut inflammation. This could be a prelude to type 1 diabetes as the bacteria causes the immune system to mistakenly attack and destroy beta cells in the pancreas that usually make insulin and monitor glucose levels.
“We know from previous human studies that changes in gut bacterial composition correlate with the early development of type 1 diabetes, and that the interactions between bacterial networks may be a contributing factor in why some people at risk for the disease develop type 1 diabetes and others don’t,” said Jessica Dunne, Director of Discovery Research at Juvenile Diabetes Research Foundation (JDRF), a UK charity which funded the study.
“This is the first study to show how specific changes in the microbiome are affecting the progression to symptomatic T1D.”
By being able to understand how the community of Continue reading

No more pages to load

Popular Articles

  • Type 2 diabetes: Study explains link to sleep hormone melatonin

    Researchers have discovered that increasing levels of the sleep hormone melatonin reduces the ability of insulin-producing cells to release insulin. Also, they found the effect is stronger in people who carry a particular gene variant that is linked to higher risk for type 2 diabetes. The study, led by Lund University in Sweden, is published in the journal Cell Metabolism. The findings mark the cu ...

  • 6 Tips For Better Sleep With Diabetes

    When you have diabetes, poor sleep can disrupt your blood sugar, your mood and your health. An estimated 40 to 50 percent of people with diabetes say they don't sleep well, according to Dr. Kingman Strohl, director of the Sleep Disorders Program at the Louis Stokes Cleveland VA Medical Center. Since quality sleep is so important to well-controlled blood sugar, making adjustments to get better shut ...

  • Sleep Apnea Treatment Can Lower Diabetes Risk

    A device used to treat sleep apnea may help people with pre-diabetes reduce their blood sugar levels and prevent full-blown diabetes in the long run, according to a new study. Patients who used a continuous positive airway pressure (CPAP) device for eight hours during sleep were less likely to develop diabetes than individuals taking an oral placebo, the research found. CPAPs blow a continuous str ...

  • You Won’t Believe the Link Between Diabetes and Sleep!

    Have an elevated risk of developing diabetes or you’re already living with the disease? READ THIS: quality and quantity of sleep is directly related to your experience. According to University of Chicago researcher Kristen Knutson, PhD, who has studied sleep and diabetes, “Sleep is an important factor for your health, as much as diet and exercise… In the past decade, there has been growing e ...

  • The Surprising Link Between Your Sleep and Gestational Diabetes

    © Mosuno / Stocksy United Quick Read Not sleeping enough may contribute to gestational diabetes Gestational diabetes, elevated blood sugar levels during pregnancy, carries significant risks for both moms and babies. A new study shows that pregnant women who sleep less are more likely to have gestational diabetes. Sleep in pregnancy is challenging. Good eating habits, exercise and avoiding screen ...

  • Newly Discovered Link Between Sleep and Diabetes Warrants Early Bedtime for Children

    Once a disease of adults, Type 2 diabetes is now affecting an increasing number of children in the United States. This disease is linked to increased insulin resistance and metabolic effects that can have devastating lifelong consequences. Doctors and scientists are struggling to discover the reason that so many children are suffering from Type 2 diabetes and other types of metabolic syndrome. New ...

  • Nottingham student with type 1 diabetes dies in his sleep | Daily Mail Online

    Another friend Molly Ellison said: 'I am so lucky to have been able to call you my best friend as well as my housemate. 'So sad to see you go so soon, a day won't go by where I don't miss you and I'll always love you and remember you forever.' Angela posted on Twitter: 'My lovely Egyptian friend Middo dabbing in memory of Tommy Green who lost his life this week to type 1 diabetes.' Another po ...

  • Managing Diabetes on Little Sleep: How to Keep Blood Sugar Controlled | Everyday Health

    Sometimes its impossible to get at least seven hours of sleep per night, but insufficient zs dont have to derail your health goals when living with diabetes. A growing body of research suggests that getting enough quality sleep is one of the most important factors in our mental and physical health. In fact, you need sleep to live and yet so many people come up short, be it due to stress, lack ...

  • Sleep-Diabetes Connection ውሑድ ድቃስ ሕማማት ሽኮርያን ልብን ብዕጽፊ የብእስ

    The Sleep-Diabetes Connection Not sleeping? Check your blood sugar levels. Whenever diabetes patients enter Lynn Maarouf’s office with out-of-control blood sugar levels, she immediately asks them how they are sleeping at night. All too often, the answer is the same: not well. “Any time your blood sugar is really high, your kidneys try to get rid of it by urinating,” says Maarouf, RD, the dia ...

Related Articles